It's been a comedy of errors, yet somehow Dr. Missling is managing to stumble forward. That there has been significant progress since he took the helm and that is also on the internet for all to see. So worst case, he's still stumbling toward the end zone. Given how low the bar is right now with the approved competition, Dr. Missling can fall ass-backwards into the end zone and it'll still count as a touchdown.
So criticize all you want. Ultimately time will tell the outcome. Whether you have the patience to see it through to the end is up to you, but I dare you to name a single successful CEO who doesn't have a track record of multiple fumbles, stumbles, missed milestones and public comments on things that never materialized or did so to significantly less fanfare than originally advertised.
Go ahead. Name a perfect CEO and let's see what the internet can dig up to prove you wrong. Everyone makes mistakes. I look at the big picture. Anavex is moving forward. I don't care if it gets there via 215 running plays in a row, or 10 passing plays or a last second Hail Mary.
Dr. Missling's value has yet to be untapped. He's a significantly better financial steward than scientist. Let's see what happens if Blarcamesine is approved and Dr. Missling's role can switch.
News 
Market Data 
Discover 
